Kyle Guse Steps Down as General Counsel and Chief Financial Officer of Atossa Therapeutics

Kyle Guse left the role of General Counsel and Chief Financial Officer at Atossa Therapeutics on May 26, 2023, according to an SEC filing.

Atossa Therapeutics disclosed that Kyle Guse ceased to serve as its general counsel and chief financial officer as of May 26, 2023, and that he is entitled to severance benefits payable upon a termination without cause. Greg Weaver succeeded him as chief financial officer effective June 1, 2023. (Source: an SEC filing.)

Other general counsel moves in May 2023

• Jas S. Hayes Named Executive Vice President, General Counsel and Corporate Secretary of JELD-WEN Holding (May 31, 2023)
• Adam Veness Steps Down as General Counsel and Secretary of Cyteir Therapeutics (May 30, 2023)
• Monica Thomas Named General Counsel of G1 Therapeutics (May 25, 2023)
• Megan Yung Named General Counsel of Eterna Therapeutics (May 25, 2023)
• Chuck Cassidy Named General Counsel of BigCommerce (May 24, 2023)
• Jeff Mengoli Steps Down as Chief Legal Officer of BigCommerce (May 24, 2023)
• Joanna M. Totsky Steps Down as Senior Vice President, Chief Legal and Transformation Officer and Secretary of Cooper-Standard Holdings (May 23, 2023)
• William B. Conway, Jr. Steps Down as Chief Corporate Development & Compliance Officer & General Counsel of Cleco (May 22, 2023)

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.